Skip to main content

Table 1 Population characteristic

From: PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content

 

PNPLA3 rs738409

CC (n = 27)

GG (n = 12)

Age (years)

38.0 (36.0–40.0)

35.0 (34.0–38.0)

BMI (kg/m2)

25.6 (21.9–32.0)

30.5 (24.8–32.8)

Overweight + obesity

15 (55%)

9 (75%)

Waist to hip ratio

0.89 (0.80–0.92)

0.92 (0.87–0.96)

GDM history

16 (59%)

6 (50%)

HbA1c %

5.5 (5.3–5.6)

5.4 (5.2–5.6)

Prediabetesa + T2DM

10 (37%)

4 (33%)

HTGC (%)b

5.5 (2.4–5.9)*

11.4 (3.8–19.1)*

NAFLD

7 (26%)+

7 (58%)+

Fasting glucose (mmol/l)

5.2 (4.9–5.3)

5.1 (5.0–5.5)

Fasting insulin (μU/ml)

10.2 (7.2–15.9)

14.0 (9.7–19.6)

Fasting TG (mmol/l)

1.0 (0.8–1.3)

1.1 (0.8–1.5)

HOMA2-IR

1.3 (1.0–2.0)

1.8 (1.3–2.5)

TyG index

7.4 (7.3–7.8)

7.6 (7.3–7.8)

  1. Medians (25th-75th percentile) or Number of patients (%) are indicated
  2. aDiagnosed by using HbA1c and/or glucose values from OGTT (IFG, IGT)
  3. bSix women had an indeterminate (− 1.455–0.676) NFS value, of which 4 patients had prediabetes/T2DM and none had pathologic FIB-4 score (> 1.45) or routine abdominal MRI scans indicating advanced liver fibrosis/cirrhosis
  4. GDM: gestational diabetes mellitus, T2DM: type 2 diabetes mellitus, HTGC: hepatic triacylglycerol content, NAFLD: non-alcoholic fatty liver disease, NFS: NAFLD fibrosis score, FIB-4 score: fibrosis-4 score
  5. *p = 0.01,+p = 0.05